9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Isolated Thoracic Perfusion (ITP-F) for MPM

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Isolated Thoracic Perfusion (ITP-F) for MPM

Isolated Thoracic Perfusion (ITP-F) for MPM

Estimated reading time: < 1 min

Condition: Mesothelioma

Estimated Enrollment: 23

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Survival,  Toxicity,  ,

Interventions: Chemotherapy,

Phase:

Study Type: Observational

Study Design: Observational Model: Case Control, Time Perspective: Prospective, ,

Primary Completion Date: January 2015

Completion Date: May 2015

Last  Posted Date: June 10, 2015

Location:

Website Link: https://ClinicalTrials.gov/show/NCT02467426

Was this article helpful?
Dislike 0